New Funding for a Research Project Focusing on CF Rare Genetic Mutations
Génome Quebec and Cystic Fibrosis Canada funding for project to develop genetic therapy for CV patients with rare mutations.
Larry Lands
View his faculty profile here: Larry Lands, MD, PhD
Professor, Department of Pediatrics, McGill University
Research Theme: Modulation of innate immunity, nutrition, and exercise limitation in pediatric lung diseases, such as asthma and cystic fibrosis
Keywords: cystic fibrosis (CF) • asthma • immune modulation • physical activity • translational research
View Larry Lands’s recent posts and news below.
King Charles III Coronation Medal Awarded to RESP Members
Jean Bourbeau and Larry Lands receive the King Charles III Coronation Medal for their outstanding contributions to Lung Health.
Trikafta Prolongs the Lives of Cystic Fibrosis Patients
Larry Lands and Elias Matouk take part in a Radia-Canada digital feature about Trikafta, a drug for Cystic Fibrosis
Spring 2023 Student Awards
Congratulations to the 2023 recipients of FRQS and CIHR studentship and fellowship awards! We wish you much success!
RESP Research Day Oral and Poster Presenter Winners – 2023
Congratulations to all of our oral and poster presenter winners from the 2023 Respiratory Research Day.
MUHC Trottier Webster Innovation Award Goes to RESP Team
Congrats to Ben Smith, Jun Ding and Larry Lands! The team received the MUHC Trottier Webster Innovation Award for their work to repair damaged lungs in COPD.
Health Matters: Reprogramming Lungs Against COPD
MUHC Foundation Health Matters interview with Ben Smith discusses reprogramming COPD lungs and with Deborah Assayag discusses ILD
Meakins and RESP Trainees Receive QRHN Funding 2021-2022
Congratulations to Wided Akik and Lisa Hennemann for their 2021-2022 QRHN awards
Spring 2021 Student Awards
Congratulations to the recipients of FRQS and CIHR studentship and fellowship awards! We wish you much success!
LAU-7b Clinical Trial on COVID-19 Treatment
Laurent Pharmaceuticals is running a clinical trial with LAU-7b that may have antiviral properties against coronavirus